A future where no child dies of neuroblastoma or suffers due to the treatment they receive
For over two decades, we have supported families across the UK affected by neuroblastoma, driven innovative clinical research, and raised awareness of the impact of childhood cancer.
We initiate and fund pioneering and best-in-class clinical research to save lives and improve outcomes for children in the UK.
We provide a family support service, led by professionals with personal experience of caring for a child with neuroblastoma.
We raise awareness of childhood cancer and advocate and campaign for positive change.
Childhood Cancer Awareness Month 2026
This September, Solving Kids' Cancer UK is joining organisations around the world in supporting Childhood Cancer Awareness Month.
DFMO Access in the UK
We want to share an update about DFMO (also known as Iwilfin or eflornithine) as the way in which DFMO is being made available in the UK has changed.
The need for our research
Clinical research brings the all-important hope that families need when facing a childhood cancer diagnosis. We are working towards a future with much-needed improved outcomes for children with neuroblastoma.
100
children in the UK are diagnosed with neuroblastoma every year.
50%
survival rate for children diagnosed with high-risk neuroblastoma.
10%
survival rate for children with high-risk neuroblastoma who relapse.
Accelerating children's cancer trials
Learn more about IMPACCT – our national initiative to accelerate clinical trials for all childhood cancers.
Solving Kids' Cancer UK Bake Off
Ready, Set, Bake! Download your Bake Off resources and get everything you need for a brilliant fundraising event.
The National Cancer Plan for England
Published in February 2026, England's National Cancer Plan includes a dedicated chapter on children and young people’s cancers.
Our latest news
Solving Kids’ Cancer UK and CCLG launch Engage
Engage is a first of its kind national initiative designed to ensure that the voices of children, young people and families affected by cancer drive meaningful change across the sector.
A Big Step Forward for Neuroblastoma Data
Solving Kids’ Cancer UK and Neuroblastoma UK are proud to have jointly awarded £50,827 over five years to fund UK participation in SIOPEN Bioportal
Statement from Solving Kids’ Cancer UK
We have published a statement recognising the sensitive nature of the BBC documentary series The Mother of All Cons and the related media coverage, outlining how we support families affected by childhood cancer.